Buchumschlag

Randomized controlled trial of intravenous dexamethasone to prevent relapse in the treatment of migraine in a pediatric emergency department

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Geneviève Tourigny‐Ruel, Benoit Bailey, Sabrina Jean‐Charles, Jocelyn Gravel
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	Headache: The Journal of Head and Face Pain
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Remote electrical neuromodulation to treat children and adolescents with migraine in the emergency department: A randomized double‐dummy pilot trial
von: Serena Laura Orr, et al.
Veröffentlicht: (2024)

2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies
von: Jennifer Robblee, et al.
Veröffentlicht: (2025)

The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies
von: Jennifer Robblee, et al.
Veröffentlicht: (2024)

Driving evidence to practice for management of migraine in the emergency department: A systematic approach to guideline implementation
von: Jennifer Robblee, et al.
Veröffentlicht: (2026)

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
von: Jessica Ailani, et al.
Veröffentlicht: (2024)

Association between wildfire smoke exposure and pediatric emergency department visits for headache
von: Hannah F. J. Shapiro, et al.
Veröffentlicht: (2025)

Plain Language Summary Publication: The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American headache society evidence assessment of parenteral pharmacotherapies
von: Jennifer Robblee, et al.
Veröffentlicht: (2024)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
von: Chia‐Chun Chiang, et al.
Veröffentlicht: (2024)

Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial
von: Anna Gryglas‐Dworak, et al.
Veröffentlicht: (2024)

Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
von: Richard B. Lipton, et al.
Veröffentlicht: (2025)

Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment
von: Joanna K. Bougie, et al.
Veröffentlicht: (2024)

Retrofitted adult interventions aren't good enough: Why children and adolescents deserve tailored evidence‐based care for migraine in the emergency department
von: Serena L. Orr
Veröffentlicht: (2026)

Comparing single‐ and repeat‐dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial
von: Emmanuelle A. D. Schindler, et al.
Veröffentlicht: (2025)

Evaluating patient and family preferences for acute and preventive pediatric headache treatment
von: Elise G. Martin, et al.
Veröffentlicht: (2024)

Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi‐country results from the CaMEO‐I study
von: Dawn C. Buse, et al.
Veröffentlicht: (2024)

A retrospective analysis of the use of candesartan for migraine prevention in adolescents
von: Irene Patniyot, et al.
Veröffentlicht: (2024)

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine
von: David Kudrow, et al.
Veröffentlicht: (2025)

Correction to “Smartphone‐delivered progressive muscle relaxation for the treatment of migraine in primary care: A randomized controlled trial”
Veröffentlicht: (2025)

Effectiveness and acceptability of oral migraine preventives: A prospective, observational study
von: Hedda S. Riise, et al.
Veröffentlicht: (2026)

Behavioral interventions for migraine prevention: A systematic review and meta‐analysis
von: Jonathan R. Treadwell, et al.
Veröffentlicht: (2025)

IV dexamethasone as adjuvant therapy to metoclopramide for acute posttraumatic headache in the ED : A randomized controlled trial
von: Kareem Joudi, et al.
Veröffentlicht: (2026)

Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial
von: Koichi Ikeda, et al.
Veröffentlicht: (2025)

Comprehensive assessment of erenumab efficacy in participants with high‐frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study
von: Gabriel Paiva da Silva Lima, et al.
Veröffentlicht: (2025)

Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper
von: Lawrence C. Newman, et al.
Veröffentlicht: (2025)

Evaluating dual calcitonin gene‐related peptide antagonists for chronic migraine prevention
von: Kara S. Graves, et al.
Veröffentlicht: (2026)

Reassessing pediatric migraine disability: Toward an updated assessment tool in the era of novel therapeutics
von: Ali Reza Tavasoli, et al.
Veröffentlicht: (2025)

Integrating gepants into clinical practice for the acute treatment of migraine
von: Richard B. Lipton, et al.
Veröffentlicht: (2026)

Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME ( US ) study
von: Jessica Ailani, et al.
Veröffentlicht: (2026)

Do antithrombotic drugs have a role in migraine prevention? A systematic review
von: Federico De Santis, et al.
Veröffentlicht: (2025)

Incidence and outcome of sudden severe headache in the emergency department
von: Ane Skaare Sjulstad, et al.
Veröffentlicht: (2025)

Response to: Reassessing pediatric migraine disability: Toward an updated assessment tool in the era of novel therapeutics
von: Christina Murphy, et al.
Veröffentlicht: (2025)

Partial rebreathing is not effective for early treatment of migraine with aura attacks: Results of a double‐blind, randomized, controlled trial ( PAREMA1 )
von: Charly Gaul, et al.
Veröffentlicht: (2025)

Unmet treatment needs in migraine: Results of the OVERCOME (US) study
von: Susan Hutchinson, et al.
Veröffentlicht: (2026)

Microneedles for the treatment of migraine and orofacial pain: A narrative review
von: Baicheng Cao, et al.
Veröffentlicht: (2026)

Calcitonin gene‐related peptide‐targeting therapies are a first‐line option for the prevention of migraine: An American Headache Society position statement update
von: Andrew C. Charles, et al.
Veröffentlicht: (2024)

Delayed urticaria during treatment with anti‐ CGRP monoclonal antibodies in migraine
von: Christoph T. Berger, et al.
Veröffentlicht: (2026)

A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study
von: Jeffrey D. Sharon, et al.
Veröffentlicht: (2024)

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study
von: Julia Peris‐Subiza, et al.
Veröffentlicht: (2025)

A 3‐year follow‐up study of outcomes associated with patterns of traditional acute and preventive migraine treatment: An administrative claims‐based cohort study in the United States
von: Shivang Joshi, et al.
Veröffentlicht: (2024)

Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment
von: Andrea M. Kuczynski, et al.
Veröffentlicht: (2025)